ABSTRACT
Introduction Contrast-mediated imaging studies and interventions are a relevant part of modern medical practice. An increasing number of patients, estimated at 30 million annually in the US, receive contrast agents during diagnostic or interventional procedures.1 One of the most important complications of contrast agents is kidney toxicity, and contrast-induced nephropathy (CIN) is one of the leading causes of renal impairment, and the third leading cause of hospital-acquired renal failure.
